Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial

  1. Sternberg, C.N.
  2. Castellano, D.
  3. Daugaard, G.
  4. Géczi, L.
  5. Hotte, S.J.
  6. Mainwaring, P.N.
  7. Saad, F.
  8. Souza, C.
  9. Tay, M.H.
  10. Garrido, J.M.T.
  11. Galli, L.
  12. Londhe, A.
  13. De Porre, P.
  14. Goon, B.
  15. Lee, E.
  16. McGowan, T.
  17. Naini, V.
  18. Todd, M.B.
  19. Molina, A.
  20. George, D.J.
Revista:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Any de publicació: 2014

Volum: 15

Número: 11

Pàgines: 1263-1268

Tipus: Article

DOI: 10.1016/S1470-2045(14)70417-6 GOOGLE SCHOLAR